Indication:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Generic Name: Gliclazide

Strength: 30mg

Dosage: MR Tabs

Shelflife Months: 18

Pack Size: 100

Tablet Description: White to off-white, round tablets, engraved with G3 on one face and plain on the other face.

Segment :A

Innovator: Glyade MR®

PBSListed: Yes

RPBSlisted: No

Schedule: S4

Storage Conditions: Store below 25 degrees celsius

Active Ingredients: gliclazide 30mg

Warnings: